GlassScriptPhysician profile
Vinay Arora
NPI 1255658993
$17,313.74
in general payments reported to CMS, 2019-2025
38 companies · $1,926 in 2025
The $1,926 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,327 · 2020: $1,647 · 2021: $1,532 · 2022: $2,411 · 2023: $2,288 · 2024: $6,184 · 2025: $1,926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,667 · Travel and Lodging: $2,387 · Entertainment: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,666.93 |
| Travel and Lodging | $2,387.07 |
| Entertainment | $343.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,593.46 | 2023-2024 | Ruby Coil, Indigo System, Smart Coil |
| Cardiovascular Systems INC. | $2,071.47 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $1,940.99 | 2019-2025 | |
| Shockwave Medical, INC | $1,043.41 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $810.17 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Janssen Pharmaceuticals, INC | $768.71 | 2019-2024 | Xarelto |
| Acist Medical Systems, INC. | $574.69 | 2024-2025 | |
| Pfizer INC. | $509.14 | 2019-2025 | |
| Abbott Laboratories | $496.73 | 2019-2025 | Cardiomems, Diamondback Peripheral |
| Abiomed | $486.32 | 2019-2025 | Impella |
| Philips North America LLC | $433.31 | 2019-2024 | (Dd1) Duo Hybrid, (Bs1) Peripheral Vascular Undivided |
| Medtronic, INC. | $386.00 | 2021-2024 | Symplicity G3, Abre, Spiderfx |
| Opsens INC. | $363.36 | 2023 | Optowire |
| E.R. Squibb & Sons, L.L.C. | $343.71 | 2022-2025 | Eliquis, Camzyos |
| Bard Peripheral Vascular, INC. | $313.53 | 2021-2024 | Lutonix Drug Coated Balloon |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $303.46 | 2022-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $257.76 | 2022-2025 | Farxiga, Brilinta |
| Lexicon Pharmaceuticals, INC. | $249.47 | 2024 | Inpefa |
| Novo Nordisk INC | $246.47 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Cardiac Dimensions, INC. | $241.65 | 2023 | |
| Edwards Lifesciences Corporation | $238.20 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.39 | 2020-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.43 | 2022-2024 | Jardiance |
| Cvrx, INC. | $187.45 | 2025 | Barostim Neo System |
| Inari Medical, INC. | $170.29 | 2020 | |
| Esperion Therapeutics, INC. | $151.53 | 2024-2025 | Nexletol |
| Biotronik INC. | $150.20 | 2020-2022 | |
| Heartflow, INC. | $142.23 | 2024-2025 | |
| Tela Bio, INC. | $128.50 | 2022 | |
| Merck Sharp & Dohme LLC | $62.72 | 2025 | Verquvo, Capvaxive |
| Livanova USA, INC. | $37.29 | 2023 | Lifesparc |
| Sanofi-Aventis U.S. LLC | $28.52 | 2023 | |
| Kestra Medical Technology Services, INC. | $23.52 | 2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $21.60 | 2023 | Optimizer |
| Cordis US Corp. | $20.44 | 2025 | Mynx Control Venous |
| Scpharmaceuticals INC. | $19.87 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $16.84 | 2024 | Arcalyst |
| Cardinal Health 200 LLC | $15.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinay Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.